Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The planned Holly Springs facility, spanning 700,000 ...

Roche and Genentech Announce New North Carolina Manufacturing Facility Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its ...

(RTTNews) - Roche Holding AG (RHHBY), Monday announced plans to invest over $700 million in a new state-of-the-art drug manufacturing facility in Holly Springs, North Carolina, creating more than ...

Genentech , a subsidiary of the Roche Group , has unveiled plans to invest more than $700 million in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, North ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, North Carolina.

Investing.com -- Roche (LON: 0QQ6) Group, the Swiss multinational healthcare company, announced on Monday that it has plans to invest over $700 million in a new drug manufacturing facility. This ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square ...

The new facility, based in Holly Springs, North Carolina, will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines. Separately, Roche also announced plans to ...

SOUTH SAN FRANCISCO, Calif., May 12, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square foot ...

The new facility, based in Holly Springs, North Carolina, will support Roche and its unit Genentech’s future portfolio of next-generation obesity medicines.